ECSS
BIO icon

Eurizon Capital SGR SpA’s Bio-Rad Laboratories Class A BIO Stock Holding History

Eurizon Capital SGR SpA’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Hold
403
– – ﹤0.01% 866
2026
Q1 		$109K Buy
403
+31
+8% +$8.93K ﹤0.01% 870
2025
Q4 		$113K Buy
+372
New +$116K ﹤0.01% 763

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Eurizon Capital SGR SpA's BIO Position: Q2 2026 in Review

Eurizon Capital SGR SpA held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 403 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Eurizon Capital SGR SpA first reported a position in BIO in Q4 2025 and has held it in 3 quarters since. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Eurizon Capital SGR SpA held 403 shares of Bio-Rad Laboratories Class A worth $119K as of Q2 2026.
  • Eurizon Capital SGR SpA left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #866 holding.
  • Eurizon Capital SGR SpA first reported a position in Bio-Rad Laboratories Class A in Q4 2025 and has held it in 3 quarters since.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.